Initial experience with Angioseal™ : Safety and efficacy of the endovascular closure device
Background: Vascular access site management is crucial to safe, efficient, and comfortable diagnostic or interventional percutaneous procedures. The Angioseal™ vascular closure device has been shown to be safe and effective in reducing the time to hemostasis following angiographic or interventional...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2013-04-01
|
Series: | Indian Journal of Radiology and Imaging |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.4103/0971-3026.116566 |
id |
doaj-b1a0f0f0fc9441c580f4450c0dda42ac |
---|---|
record_format |
Article |
spelling |
doaj-b1a0f0f0fc9441c580f4450c0dda42ac2021-10-04T23:09:14ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Radiology and Imaging0971-30261998-38082013-04-01230213413810.4103/0971-3026.116566Initial experience with Angioseal™ : Safety and efficacy of the endovascular closure deviceSachin Modi0Rakesh Gadvi1Suresh Babu2Department of Interventional Radiology, Sandwell and West Birmingham NHS Trust, Birmingham, West MidlandsDepartment of Interventional Radiology, Sandwell and West Birmingham NHS Trust, Birmingham, West MidlandsDepartment of Interventional Radiology, Sandwell and West Birmingham NHS Trust, Birmingham, West MidlandsBackground: Vascular access site management is crucial to safe, efficient, and comfortable diagnostic or interventional percutaneous procedures. The Angioseal™ vascular closure device has been shown to be safe and effective in reducing the time to hemostasis following angiographic or interventional procedures. Relatively few studies have been conducted in the UK to assess the safety and efficacy of the device in a local setting. Materials and Methods: Data were retrospectively reviewed on 147 patients who underwent either diagnostic angiography or percutaneous interventional procedures from January 2008 to October 2009, and who had the femoral access site closed by 6F VIP Angioseal. A total of 147 patients (F: 49, M: 98), including 80 right femoral punctures, 57 left femoral punctures, and 10 bilateral punctures were reviewed using radiological reports and patients′ clinical data. Data on antiplatelet and anticoagulant therapy were recorded. All procedures were carried out by two interventional radiologists at a single institution, under similar operating conditions. Results: There were a total of six complications (4.47%), of which one was a major complication (0.75%), i.e., retroperitoneal bleed. There were five minor complications (3.73%), which included device deployment failure (2), device malfunction (2), and a superficial hematoma (>6 cm). Total complications were 6 out of 157 (3.8%) [95% CI = 0.8-6.8%)]. Successful hemostasis was achieved in less than 5 min in over 97% of patients. Successful device deployment was seen in over 98% of cases. Conclusion: We conclude that in our experience, the Angioseal vascular closure device is a safe and efficient means of achieving hemostasis post antegrade or retrograde puncture for diagnostic and percutaneous intervention procedures.http://www.thieme-connect.de/DOI/DOI?10.4103/0971-3026.116566angiographyangioseal™endovascular interventionvascular access site closure |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sachin Modi Rakesh Gadvi Suresh Babu |
spellingShingle |
Sachin Modi Rakesh Gadvi Suresh Babu Initial experience with Angioseal™ : Safety and efficacy of the endovascular closure device Indian Journal of Radiology and Imaging angiography angioseal™ endovascular intervention vascular access site closure |
author_facet |
Sachin Modi Rakesh Gadvi Suresh Babu |
author_sort |
Sachin Modi |
title |
Initial experience with Angioseal™ : Safety and efficacy of the endovascular closure device |
title_short |
Initial experience with Angioseal™ : Safety and efficacy of the endovascular closure device |
title_full |
Initial experience with Angioseal™ : Safety and efficacy of the endovascular closure device |
title_fullStr |
Initial experience with Angioseal™ : Safety and efficacy of the endovascular closure device |
title_full_unstemmed |
Initial experience with Angioseal™ : Safety and efficacy of the endovascular closure device |
title_sort |
initial experience with angioseal™ : safety and efficacy of the endovascular closure device |
publisher |
Thieme Medical and Scientific Publishers Pvt. Ltd. |
series |
Indian Journal of Radiology and Imaging |
issn |
0971-3026 1998-3808 |
publishDate |
2013-04-01 |
description |
Background: Vascular access site management is crucial to safe, efficient, and comfortable diagnostic or interventional percutaneous procedures. The Angioseal™ vascular closure device has been shown to be safe and effective in reducing the time to hemostasis following angiographic or interventional procedures. Relatively few studies have been conducted in the UK to assess the safety and efficacy of the device in a local setting. Materials and Methods: Data were retrospectively reviewed on 147 patients who underwent either diagnostic angiography or percutaneous interventional procedures from January 2008 to October 2009, and who had the femoral access site closed by 6F VIP Angioseal. A total of 147 patients (F: 49, M: 98), including 80 right femoral punctures, 57 left femoral punctures, and 10 bilateral punctures were reviewed using radiological reports and patients′ clinical data. Data on antiplatelet and anticoagulant therapy were recorded. All procedures were carried out by two interventional radiologists at a single institution, under similar operating conditions. Results: There were a total of six complications (4.47%), of which one was a major complication (0.75%), i.e., retroperitoneal bleed. There were five minor complications (3.73%), which included device deployment failure (2), device malfunction (2), and a superficial hematoma (>6 cm). Total complications were 6 out of 157 (3.8%) [95% CI = 0.8-6.8%)]. Successful hemostasis was achieved in less than 5 min in over 97% of patients. Successful device deployment was seen in over 98% of cases. Conclusion: We conclude that in our experience, the Angioseal vascular closure device is a safe and efficient means of achieving hemostasis post antegrade or retrograde puncture for diagnostic and percutaneous intervention procedures. |
topic |
angiography angioseal™ endovascular intervention vascular access site closure |
url |
http://www.thieme-connect.de/DOI/DOI?10.4103/0971-3026.116566 |
work_keys_str_mv |
AT sachinmodi initialexperiencewithangiosealsafetyandefficacyoftheendovascularclosuredevice AT rakeshgadvi initialexperiencewithangiosealsafetyandefficacyoftheendovascularclosuredevice AT sureshbabu initialexperiencewithangiosealsafetyandefficacyoftheendovascularclosuredevice |
_version_ |
1716843843764092928 |